Applied BioCode Dionica

Applied BioCode EV/FCF

EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) tvrtke Applied BioCode (6598.TW) na dan 24. kol 2026. iznosi −8,08. Prethodne godine EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) je iznosio −7,60 — promjena od 6,36% (manji).

EV/FCF

−8,08

YoY

6,36%

Zadnje ažuriranje:

EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) tvrtke Applied BioCode iznosi 2026 −8,08 . EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) tvrtke Applied BioCode iznosio je 2025 −7,60 . Pada za 6,36% manji u odnosu na prethodnu godinu.

Povijest Applied BioCode EV/FCF

  • 3 godine

  • 10 godina

  • 25 godina

  • Max

EV/FCF
Date
EV/FCF
1. sij 2018.
−6,96 TWD
1. sij 2019.
−6,46 TWD
1. sij 2020.
−9,65 TWD
1. sij 2021.
−11,22 TWD
1. sij 2022.
13,66 TWD
1. sij 2023.
−8,99 TWD
1. sij 2024.
−7,60 TWD
1. sij 2025.
−8,08 TWD
Povijest Applied BioCode EV/FCF
GODINAEV/FCFYoY
−8,08+6,36%
−7,60−15,52%
−8,99−165,84%
13,66−221,77%
−11,22+16,24%
−9,65+49,50%
−6,46−7,19%
−6,96−19,94%
−8,69+89,50%
−4,59−52,11%
−9,57−41,78%
−16,45
Access this data via the Eulerpool API

Applied BioCode Analiza dionica

Što radi Applied BioCode? Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode je jedna od najpopularnijih tvrtki na Eulerpool.com.

Često postavljana pitanja o dionici Applied BioCode

EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) tvrtke Applied BioCode iznosi −8,08 u 2026. godini.

EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) tvrtke Applied BioCode se promijenio s −7,60 na −8,08, što predstavlja promjenu od 6,36 %. Vrijednost je manji nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni povijesni razvoj Applied BioCode tvrtke EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku) od 2006. – s godišnjim vrijednostima, grafikonima i detaljnim analizama.

Omjer EV/FCF mjeri vrijednost poduzeća u odnosu na slobodni novčani tok i hvata stvarnu sposobnost poduzeća da generiše novčani tok.

Za procjenu EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku)s, bitno je usporediti ga s konkurentima u istoj branši i sektoru. Na Eulerpool-u možete pronaći izravne usporedbe s industrijom za EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku).

Dobra vrijednost za varira po branši i fazi razvoja. Na Eulerpool-u možete usporediti EV/FCF (Vrijednost poduzeća prema slobodnom novčanom toku)s Applied BioCode sa sličnim poduzećima u sektoru i prosječnom vrijednosti u industriji kako biste procijenili je li privlačna.

Access this data via the Eulerpool API

Vrednovanje — Applied BioCode

Sve ključne metrike — Applied BioCode